{
    "id": "de390dba-9d99-4525-9c2d-32ecfaec0b6b",
    "indications": "mibelas 24 fe estrogen/progestin coc indicated women prevent pregnancy ( 1 ) efficacy women body mass index 35 kg/m 2 evaluated ( 1 , 8.8 )",
    "contraindications": "one tablet daily chewed swallowed swallowed whole taken time day . follow 8 ounces water ( 2.1 ) take one tablet mouth time every day 28 days ( 2.1 ) take tablets order directed blister pack ( 2.1 ) tablets may administered without regard meals ( 12.3 )",
    "adverseReactions": "high risk arterial venous thrombotic diseases ( 4 ) breast cancer liver tumors liver disease ( 4 ) undiagnosed abnormal uterine bleeding ( 4 ) pregnancy ( 4 ) co-administration hepatitis c combinations containing ombitasvir/paritaprevir/ritonavir , without dasabuvir ( 4 )",
    "ingredients": [],
    "organization": "Lupin Pharmaceuticals, Inc.",
    "name": "Mibelas 24 Fe",
    "effectiveTime": "20250523",
    "indications_original": "Mibelas 24 Fe is an estrogen/progestin COC indicated for use by women to prevent pregnancy ( 1 ) The efficacy in women with a body mass index of more than 35 kg/m 2 has not been evaluated ( 1 , 8.8 )",
    "contraindications_original": "One tablet daily chewed and swallowed or swallowed whole taken at the same time of day. Follow with 8 ounces of water ( 2.1 ) Take one tablet by mouth at the same time every day for 28 days ( 2.1 ) Take tablets in the order directed on the blister pack ( 2.1 ) Tablets may be administered without regard to meals ( 12.3 )",
    "adverseReactions_original": "A high risk of arterial or venous thrombotic diseases ( 4 ) Breast cancer Liver tumors or liver disease ( 4 ) Undiagnosed abnormal uterine bleeding ( 4 ) Pregnancy ( 4 ) Co-administration with Hepatitis C drug combinations containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir ( 4 )"
}